MKVBX
Price
$18.71
Change
-$0.05 (-0.27%)
Updated
Jul 13 closing price
Net Assets
7.31B
TRWTX
Price
$28.29
Change
-$0.28 (-0.98%)
Updated
Jul 13 closing price
Net Assets
4.32B
Interact to see
Advertisement

MKVBX vs TRWTX

MKVBX vs TRWTX Comparison Chart in %
View a ticker or compare two or three
VS
MKVBX vs. TRWTX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKVBX is a StrongBuy and TRWTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MKVBX has more cash in the bank: 7.31B vs. TRWTX (4.32B). TRWTX pays higher dividends than MKVBX: TRWTX (3.43) vs MKVBX (3.10). MKVBX was incepted earlier than TRWTX: MKVBX (6 years) vs TRWTX (34 years). MKVBX (0.99) is less costly to investors than TRWTX (0.76). MKVBX is a more actively managed with annual turnover of: 22.00 vs. TRWTX (13.00). TRWTX has a lower initial minimum investment than MKVBX: TRWTX (0) vs MKVBX (1000). MKVBX annual gain was more profitable for investors over the last year : 21.73 vs. TRWTX (20.47). MKVBX return over 5 years is better than : 58.35 vs. TRWTX (49.42).
MKVBXTRWTXMKVBX / TRWTX
Total Expense Ratio0.960.76126%
Annual Report Gross Expense Ratio0.990.76130%
Fund Existence6 years34 years-
Gain YTD11.80013.50887%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.31B4.32B169%
Annual Yield % from dividends3.103.4391%
Returns for 1 year21.7320.47106%
Returns for 3 years55.4553.74103%
Returns for 5 years58.3549.42118%
Returns for 10 yearsN/A112.38-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANVIX30.72N/A
N/A
Virtus NFJ Large-Cap Value Fund Inst
BDHAX9.08N/A
N/A
BlackRock Dynamic High Income Inv A
PAGHX143.05N/A
N/A
Permanent Portfolio Aggressive Growth C
UPAAX23.06N/A
N/A
Upright Assets Allocation Plus
JAGLX87.72-0.68
-0.77%
Janus Henderson Global Life Sciences T